carboplatin,gemcitabine,paclitaxel,vinorelbine,cisplatin,nivolumab,docetaxel,pemetrexed,ipilimumab,pembrolizumab
merck,bms
[]
 sad. a condemnation of the regulatory (and taxpayer) capture we face in the 
Oncologist | RadOnc | Stats #Rstats | Opinion | Politics | Never Trump